Anida Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Anida Pharma General Information

Description

Developer of a biopharmaceutical therapy designed to prevent and slow the progression of ocular disease. The company's platform specializes in a pipeline of treatments that target sensory organ dysfunction with an initial focus on unmet medical needs in pediatric patients, enabling medical professionals to prevent and restore neuro-sensory dysfunction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 155 Brookline Street
  • Suite 005
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 155 Brookline Street
  • Suite 005
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anida Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 21-Dec-2020 Completed Clinical Trials - Phase 1
2. Angel (individual) 15-Oct-2015 Cancelled Clinical Trials - Phase 1
1. Grant 27-Sep-2013 Completed Clinical Trials - Phase 1
To view Anida Pharma’s complete valuation and funding history, request access »

Anida Pharma Patents

Anida Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025259966-A1 Pharmaceutical formulations comprising a salt of a docosahexaenoic acid (dha) analog Pending 14-Jun-2024
US-20250381161-A1 Compositions and methods for treating hearing and ocular disorders Pending 21-Jun-2022
WO-2023250031-A1 Compositions and methods for treating hearing and ocular disorders Inactive 21-Jun-2022
ES-2773310-T3 Methods for treating ototoxicity Active 28-Feb-2013
EP-2961401-A1 Methods of treating ototoxicity Active 28-Feb-2013 A61K31/202
To view Anida Pharma’s complete patent history, request access »

Anida Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
CH Innovations Not-For-Profit Venture Capital Minority
To view Anida Pharma’s complete investors history, request access »

Anida Pharma FAQs

  • When was Anida Pharma founded?

    Anida Pharma was founded in 2013.

  • Where is Anida Pharma headquartered?

    Anida Pharma is headquartered in Cambridge, MA.

  • What industry is Anida Pharma in?

    Anida Pharma’s primary industry is Drug Discovery.

  • Is Anida Pharma a private or public company?

    Anida Pharma is a Private company.

  • What is Anida Pharma’s current revenue?

    The current revenue for Anida Pharma is .

  • Who are Anida Pharma’s investors?

    CH Innovations has invested in Anida Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process